The Cancer Institute of New Jersey (CINJ), an NCI-Designated Comprehensive Cancer Center, is a matrix style, basic, clinical and population research center under the auspices of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School. The Director serves as Associate Dean for Oncology Programs and is responsible for integrating research at the medical school with the Robert Wood Johnson University Hospital, School of Public Health, and several schools and departments of Rutgers, The State University of New Jersey.

Established in 1991, CINJ is one of the Nation’s most rapidly growing cancer centers with a growth rate in its patient visits of 8% per month. Starting from a patient base of zero in 1993, CINJ physicians cared for close to 75,000 patient visits in 2004.

The research base of CINJ, which is supported by more than $80 million annually in cancer-related research grants, is organized into eight programs: Breast Cancer Research; Cancer Pharmacology/Developmental Therapeutics; Carcinogenesis and Chemoprevention; Cytokines, Cytokine Signaling and Cancer; Molecular Mechanisms of Tumor Growth; Prostate; Population Science, and Transcriptional Regulation and Oncogenesis.